Alpha IVF Group Berhad (KLSE:ALPHA)

Market Cap	1.46B
Revenue (ttm)	176.84M
Net Income (ttm)	57.45M
Shares Out	4.86B
EPS (ttm)	0.01
PE Ratio	25.38
Forward PE	21.43
Dividend	0.01 (3.28%)
Ex-Dividend Date	Aug 8, 2025

Volume	2,398,200
Average Volume	1,945,015
Open	0.3050
Previous Close	0.3050
Day's Range	0.3000 - 0.3100
52-Week Range	0.2650 - 0.3750
Beta	n/a
RSI	55.18
Earnings Date	Oct 23, 2025

About Alpha IVF Group Berhad

Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia and Singapore. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation optimisation; sperm sorting; and egg freezing, embryo freezing and c...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2011
• Employees: 150
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: ALPHA

Financial Performance

In 2025, Alpha IVF Group Berhad's revenue was 176.84 million, an increase of 5.52% compared to the previous year's 167.59 million. Earnings were 57.45 million, an increase of 8.54%.